BG101113A - Триазолови съединения и тяхното използване - Google Patents

Триазолови съединения и тяхното използване

Info

Publication number
BG101113A
BG101113A BG101113A BG10111397A BG101113A BG 101113 A BG101113 A BG 101113A BG 101113 A BG101113 A BG 101113A BG 10111397 A BG10111397 A BG 10111397A BG 101113 A BG101113 A BG 101113A
Authority
BG
Bulgaria
Prior art keywords
triazole compounds
application
compounds
todopamine
ortriazinyl
Prior art date
Application number
BG101113A
Other languages
English (en)
Other versions
BG63500B1 (bg
Inventor
Beate Hellendahl
Annegret Lansky
Rainer Munschauer
Siegfried Bialojan
Liliane Unger
Hans-Juergen Teschendorf
Karsten Wicke
Karla Drescher
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6523323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG101113(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG101113A publication Critical patent/BG101113A/bg
Publication of BG63500B1 publication Critical patent/BG63500B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Изобретението се отнася до триазолови съединения с формула, в която R1 и R2 означават водород или различни заместители, А - двувалентна група, В - остатък с формула a, b или с и Ar означава в даден случай заместен фенил, пиридил, пиримидил или триазинил. Съединенията имат повишен афинитет към допамин-D3-рецепторите и могат да се използват при лечение на заболявания, които реагират на допамин-D3-лиганди.
BG101113A 1994-07-15 1997-01-06 Триазолови съединения и тяхното използване BG63500B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4425144A DE4425144A1 (de) 1994-07-15 1994-07-15 Triazolverbindungen und deren Verwendung
PCT/EP1995/002781 WO1996002520A1 (de) 1994-07-15 1995-07-14 Triazolverbindungen und deren verwendung als dopamin-d3-liganden

Publications (2)

Publication Number Publication Date
BG101113A true BG101113A (bg) 1998-04-30
BG63500B1 BG63500B1 (bg) 2002-03-29

Family

ID=6523323

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101113A BG63500B1 (bg) 1994-07-15 1997-01-06 Триазолови съединения и тяхното използване

Country Status (23)

Country Link
US (1) US6124294A (bg)
EP (1) EP0772604B1 (bg)
KR (1) KR100379196B1 (bg)
CN (1) CN1068314C (bg)
AT (1) ATE179703T1 (bg)
AU (1) AU703889B2 (bg)
BG (1) BG63500B1 (bg)
BR (1) BR9508294A (bg)
CA (1) CA2195243C (bg)
CZ (1) CZ292625B6 (bg)
DE (2) DE4425144A1 (bg)
DK (1) DK0772604T3 (bg)
ES (1) ES2131842T3 (bg)
FI (1) FI970147A0 (bg)
GR (1) GR3030371T3 (bg)
HU (1) HU225961B1 (bg)
IL (1) IL114598A (bg)
NO (1) NO315320B1 (bg)
NZ (1) NZ290387A (bg)
RU (1) RU2167869C2 (bg)
SI (1) SI9520083A (bg)
WO (1) WO1996002520A1 (bg)
ZA (1) ZA955867B (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600934A1 (de) 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
MA26696A1 (fr) 1998-10-08 2004-12-20 Smithkline Beecham Plc Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
AU7989400A (en) 1999-10-01 2001-05-10 Smithkline Beecham Corporation Compounds and methods
AU2001250404A1 (en) * 2000-03-27 2001-10-08 Basf Aktiengesellschaft Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
DE10109867A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
US7605259B2 (en) 2002-09-14 2009-10-20 University Of North Texas Health Science Center At Fort Worth Structurally rigid dopamine d3 receptor selective ligands and process for making them
CZ300500B6 (cs) * 2002-11-11 2009-06-03 Zpusob uzavírání špic v pletacím stroji
DE10304870A1 (de) 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
JP2004359689A (ja) * 2003-06-05 2004-12-24 Abbott Gmbh & Co Kg ドーパミンｄ３受容体のモジュレーションに反応する障害の治療に適するトリアゾール化合物
US6919342B2 (en) 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DE10358004A1 (de) 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
WO2005058328A1 (en) 2003-12-18 2005-06-30 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
US20050137186A1 (en) 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
JP4904267B2 (ja) * 2004-08-09 2012-03-28 アボット ゲーエムベーハー ウント カンパニー カーゲー ドーパミンｄ３受容体の調節に応答する障害の治療に好適な４−ピペラジニル−ピリミジン化合物
US8101754B2 (en) * 2004-12-02 2012-01-24 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
CN101827828B (zh) * 2007-08-07 2013-02-27 普罗萨里克斯有限公司 作为5-羟色胺能调节剂的1,2,4-三唑衍生物
PA8802101A1 (es) 2007-11-02 2009-08-26 Abbott Gmbh & Co Kg Compuestos de 1,2,4-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina d3
CN102076671B (zh) * 2008-07-03 2013-05-15 安斯泰来制药有限公司 三唑衍生物或其盐

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (bg) * 1964-03-26
US4408049A (en) * 1980-09-17 1983-10-04 The Upjohn Company Substituted piperazinyl-1,2,4-triazoles
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4577020A (en) * 1983-01-25 1986-03-18 The Upjohn Company Aminoalkyl and aminoalkenyl triazoles as anti-psychotic agents
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
FR2580648B1 (fr) * 1985-04-17 1987-05-15 Adir Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2601952B1 (fr) * 1986-07-23 1988-11-25 Carpibem Nouveaux derives amino alkyl thio de triazolopyridine ou triazoloquinoline, leurs procedes de preparation, medicaments les contenant, utiles notamment comme antalgiques
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Also Published As

Publication number Publication date
FI970147A (fi) 1997-01-14
CZ9797A3 (en) 1997-08-13
IL114598A0 (en) 1995-11-27
JP4114950B2 (ja) 2008-07-09
ATE179703T1 (de) 1999-05-15
CN1068314C (zh) 2001-07-11
NZ290387A (en) 1999-02-25
CA2195243A1 (en) 1996-02-01
AU703889B2 (en) 1999-04-01
CZ292625B6 (cs) 2003-11-12
JPH10502914A (ja) 1998-03-17
SI9520083A (en) 1997-10-31
KR100379196B1 (ko) 2003-06-11
KR970704710A (ko) 1997-09-06
HU9700109D0 (en) 1997-02-28
WO1996002520A1 (de) 1996-02-01
AU3111395A (en) 1996-02-16
HU225961B1 (en) 2008-01-28
CN1152919A (zh) 1997-06-25
HUT77128A (hu) 1998-03-02
BG63500B1 (bg) 2002-03-29
FI970147A0 (fi) 1997-01-14
EP0772604A1 (de) 1997-05-14
DE4425144A1 (de) 1996-01-18
IL114598A (en) 1999-12-22
BR9508294A (pt) 1997-12-30
NO315320B1 (no) 2003-08-18
ZA955867B (en) 1997-01-14
US6124294A (en) 2000-09-26
ES2131842T3 (es) 1999-08-01
NO970161L (no) 1997-03-14
EP0772604B1 (de) 1999-05-06
NO970161D0 (no) 1997-01-14
GR3030371T3 (en) 1999-09-30
DK0772604T3 (da) 1999-11-01
RU2167869C2 (ru) 2001-05-27
DE59505853D1 (de) 1999-06-10
CA2195243C (en) 2006-05-30

Similar Documents

Publication Publication Date Title
BG101113A (bg) Триазолови съединения и тяхното използване
KR0156252B1 (en) Difluoromethyl compound
BG105783A (bg) Триазоли с допамин-d3 рецепторен афинитет
BG101112A (bg) Използване на хетероциклени съединения
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG102425A (bg) (метилсулфонил)фенил-2-(5н)-фуранони като инхибитори на циклооксигеназа-2
BG102704A (bg) Фунгицидни 2-метоксибензофенони
MY102741A (en) Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
EP0984778A4 (en) NEUROPEPTIDE LIGANDS Y
NZ502181A (en) Triazole compounds and the use thereof as dopamine-D 3-ligands
BG103485A (bg) Кетобензамиди като инхибитори на калпаина
CA2241787A1 (en) Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
CA2051693A1 (en) Allosteric hemoglobin modifiers
BG103310A (bg) Бензонафтиридини като бронхиални лечебни средства
MY105344A (en) New sulphonyl compounds
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
MY129863A (en) Biocidal composition
NZ515025A (en) Solvates of pymetrozine
TW351718B (en) Acylated aminoalkanimidazoles and -triazoles
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ZA912740B (en) Anti-corrosive pigmentary composition for coatings
MX9700624A (es) Azolidinonas de imidazopiridina.
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas